3-methyl-2- ( (2s) -2- (4- (3-methyl-1, 2, 4-oxadiazol-5-yl)...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 413/14 (2006.01) A61K 31/5377 (2006.01) A61P 25/00 (2006.01)

Patent

CA 2698818

A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof: which is used for preventive and/or therapeutic treatment of a disease caused by abnormal activity of tau protein kinase 1 such as a neurodegenerative diseases (e.g. Alzheimer disease).

La présente invention concerne un composé représenté par la formule (I) ou un sel pharmaceutiquement acceptable de celui-ci : qui est utilisé pour le traitement préventif et/ou thérapeutique d'une maladie causée par une activité anormale de la protéine TAU kinase 1, telle que des maladies neurodégénératives (notamment la maladie d'Alzheimer).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

3-methyl-2- ( (2s) -2- (4- (3-methyl-1, 2, 4-oxadiazol-5-yl)... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-methyl-2- ( (2s) -2- (4- (3-methyl-1, 2, 4-oxadiazol-5-yl)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-methyl-2- ( (2s) -2- (4- (3-methyl-1, 2, 4-oxadiazol-5-yl)... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1906652

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.